14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ZH vs RERE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, ATRenew Inc. (RERE) is the stronger overall head-to-head candidate over Zhihu Inc. (ZH) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ZH carries a Unified Composite Score of 59.3/100 (HOLD) at $2.53 (37.3x Forward P/E, -14.2% operating margin), whereas RERE carries 48.6/100 (HOLD) at $4.03 (8.5x Forward P/E, 2.7% operating margin).
Composite vs. Pillar Nuance: While ZH currently prints a higher short-term Unified Composite Score (59.3/100 HOLD vs. RERE 48.6/100 HOLD), RERE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (2.7% vs. -14.2% operating margin) and revenue trajectory (+32.4% vs. -3.7% YoY).
Technical & Structure Timing Caution: ZH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.8); meanwhile RERE is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZH vs RERE. Trailing 12-month operating profitability (ZH -14.2% vs RERE 2.7%) and valuation multiples (ZH 37.3x vs RERE 8.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Internet Retail value chain with $855.0M market capitalization and 2.7% operating margin.
OpEx & R&D Reinvestment18.0% of Rev ($555M)
90D Engineering Disclosures0 Published
Investor FAQ ZH vs RERE Key Questions & Quantitative Answers
As of Nov 16, 2026, ATRenew Inc. (RERE) is the stronger overall head-to-head candidate over Zhihu Inc. (ZH) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ZH carries a Unified Composite Score of 59.3/100 (HOLD) at $2.53 (37.3x Forward P/E, -14.2% operating margin), whereas RERE carries 48.6/100 (HOLD) at $4.03 (8.5x Forward P/E, 2.7% operating margin). Composite vs. Pillar Nuance: While ZH currently prints a higher short-term Unified Composite Score (59.3/100 HOLD vs. RERE 48.6/100 HOLD), RERE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (2.7% vs. -14.2% operating margin) and revenue trajectory (+32.4% vs. -3.7% YoY). Technical & Structure Timing Caution: ZH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.8); meanwhile RERE is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
RERE leads the Growth & Scale pillar: ZH posts -3.7% YoY revenue growth and +0.0% YoY earnings growth on $2.64B TTM revenue (57.9% gross margin, -14.2% operating margin), compared with RERE at +32.4% YoY revenue growth and +81.8% YoY earnings growth on $3.09B TTM revenue (20.7% gross margin, 2.7% operating margin). On trailing 12-month operating scale, ZH generates $2.64B in USD-normalized revenue versus $3.09B for RERE. In operating R&D and SG&A reinvestment, ZH deploys 72.1% of Rev ($1.91B) (0 90-day corporate R&D disclosures) versus 18.0% of Rev ($555M) (0 disclosures) for RERE.
RERE screens cheaper on headline valuation multiples. ZH trades at 37.3x Forward P/E, 37.3x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin), whereas RERE trades at 8.5x Forward P/E, 13.8x Trailing P/E, N/M PEG, and 0.3x EV/Revenue (2.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ZH (-7.6% ROE) versus RERE (12.3% ROE) capital efficiency.
In options market volatility and institutional positioning, ZH carries 57.0% implied volatility (50th %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.05β · 54% Vol realized risk). By comparison, RERE carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.99β · 56% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.